If you've searched "clonazepam shortage" after leaving a pharmacy counter empty-handed, you probably assumed this works like the Adderall or Vyvanse headlines you've seen — a nationwide quota fight, months of dead stock, no end in sight. It doesn't. Clonazepam's supply problem in 2026 is smaller, narrower, and traces back to one manufacturer rather than a federal ceiling on how much can legally be made. That's genuinely good news, but it also means the fix looks different, and most of the advice written for stimulant shortages doesn't quite apply here.
1. Is Clonazepam Really in Shortage?
Yes, in a limited sense. ASHP's shortage bulletin for clonazepam oral tablets lists Teva as the manufacturer currently reporting a problem: its 0.5 mg and 2 mg tablets, in 100-count bottles, are on intermittent back order, and the stated reason is increased demand rather than a raw-material or manufacturing issue. Everyone else on that same bulletin — Accord, Chartwell, Solco, and H2 Pharma, which markets brand-name Klonopin — reports clonazepam availability as current.
What "shortage" means here: One manufacturer, two of its three strengths, one package size, one reported cause. If your pharmacy's wholesaler happens to source Teva product, you can absolutely hit an empty shelf. If they source from Accord, Solco, Chartwell, or stock brand Klonopin, you likely won't notice anything at all.
That's a meaningfully smaller problem than what's happening with generic lisdexamfetamine or amphetamine salts right now, where multiple separate manufacturers are short at the same time because of a federal production ceiling. Clonazepam availability, overall, is closer to normal than not — this is a patchy, manufacturer-specific gap, not a category-wide crunch.
2. Why This Shortage Doesn't Work Like Adderall's
Adderall and Vyvanse are Schedule II controlled substances. Clonazepam is Schedule IV. That single classification difference explains almost everything about why the two shortages behave so differently.
Under the Controlled Substances Act, the DEA sets an annual aggregate production quota — a hard ceiling on how much active ingredient every manufacturer combined is legally allowed to produce — but only for Schedule I and Schedule II substances. Schedule IV drugs, including clonazepam, alprazolam, and lorazepam, aren't subject to that quota system at all. There's no federal cap capable of squeezing every manufacturer at once the way there is for stimulants.
The practical difference: When one Schedule II manufacturer has a problem, the fix depends partly on a DEA quota adjustment that can take months. When one Schedule IV manufacturer like Teva has a problem, the other manufacturers already have room to produce more, because nothing is capping their output. That's a large part of why Accord, Solco, Chartwell, and Klonopin's distributor aren't also reporting shortages.
Demand is the other half of the story. Prescriptions for anxiety and panic-disorder medications have climbed steadily in recent years, and clonazepam is one of the more commonly prescribed benzodiazepines for both anxiety and seizure disorders. Teva's own explanation — increased demand — fits that pattern: more prescriptions competing for the same production capacity at one company, rather than a supply chain breaking down industry-wide.
3. Timeline: How This Developed
| Date | Event |
|---|---|
| March 2023 | ASHP first posts a current-shortage listing for clonazepam oral tablets |
| 2023–2024 | Multiple strengths and manufacturers show intermittent gaps as demand for benzodiazepines rises industry-wide |
| Aug 19, 2025 | Solco reverifies its clonazepam tablets as available on ASHP's tracking |
| Oct 28, 2025 | Teva's listing is updated: 0.5 mg and 2 mg tablets (100-count) confirmed on intermittent back order, citing increased demand |
| Jan 5, 2026 | Additional NDCs reverified as available across generic manufacturers, per ASHP updates |
| 2026 (ongoing) | Teva remains the only manufacturer reporting a shortage; Accord, Chartwell, Solco, and brand Klonopin (H2 Pharma) continue to report availability |
4. Manufacturer Status by Strength
Because this shortage sits with one company, checking manufacturer and strength together tells you almost everything you need before you even call a pharmacy.
| Manufacturer | 0.5 mg | 1 mg | 2 mg |
|---|---|---|---|
| H2 Pharma (Klonopin, brand) | Available | Available | Available |
| Accord | Available | Available | Available |
| Chartwell | Available | Available | Available |
| Solco | Available | Available | Available |
| Teva | Intermittent back order | Available | Intermittent back order |
Practical tip: Ask your pharmacist which manufacturer's clonazepam they currently carry before assuming the whole medication is unavailable. A store that stocks only Teva may be out of your 0.5 mg or 2 mg tablets specifically, while a store two miles away carrying Accord or Solco has full supply of every strength.
5. The Schedule IV Refill Advantage
This is the piece most shortage guides skip, because most of them are written for Schedule II stimulants where it doesn't apply. Clonazepam prescriptions can generally be refilled up to five times within six months from the date they were written, without your prescriber writing anything new. Vyvanse and Adderall prescriptions can't be refilled at all — every single fill legally requires a brand-new prescription.
What this means in practice: If you have refills remaining and your usual pharmacy is out of stock, you can often call a different pharmacy and ask them to transfer the prescription, refills included, without contacting your prescriber's office at all. Some states cap how many times a controlled-substance prescription can be transferred, so confirm with the receiving pharmacy, but this route is available to clonazepam patients in a way it simply isn't for Schedule II patients.
Clonazepam refill rules also mean planning ahead is more forgiving. If you know your pharmacy has had trouble stocking Teva product before, ask them proactively which manufacturer they're filling from a week before you're due, rather than finding out at the counter.
6. When Will the Clonazepam Shortage End?
There's no published resolution date, and Teva hasn't listed one. Its bulletin describes the back order as intermittent, with supply released as it becomes available, which is a different kind of language than "discontinued" or "no estimate" — it suggests periodic restocking rather than a stalled pipeline.
What would actually resolve it: Teva increasing production or catching up with demand at its own facilities. Because that's a single-company issue rather than a quota-capped, industry-wide one, most patients don't need to wait for it to resolve at all — sourcing clonazepam from Accord, Solco, Chartwell, or brand Klonopin already solves the practical problem today.
The realistic outlook for the rest of 2026: expect Teva's 0.5 mg and 2 mg 100-count bottles to remain spotty at pharmacies that rely on that manufacturer, while overall clonazepam availability, across all manufacturers combined, stays close to normal.
7. Brand vs. Generic: Cost & Coverage
Clonazepam is one of the cheaper controlled substances to fill in cash terms, which changes the cost conversation compared to something like Vyvanse.
- Generic clonazepam: Typically around $25 to $45 for 30 tablets at cash price, and a free discount card can often bring that down to roughly $8 to $15 depending on dose and pharmacy.
- Brand Klonopin: Runs substantially higher out of pocket, commonly $100 or more for a comparable supply, since it doesn't benefit from generic competition pricing at the pharmacy counter.
- Insurance coverage: Most commercial and Medicare Part D formularies place generic clonazepam in a low, preferred tier. Brand Klonopin is typically non-preferred or excluded once a generic equivalent exists, similar to how other brand-generic pairs are handled.
The coupon gap: Larger originator companies, like the makers of Vyvanse or GLP-1 drugs, often run manufacturer copay cards and dedicated patient assistance programs. Brand Klonopin doesn't have that infrastructure behind it right now — H2 Pharma, its current distributor, is a smaller specialty company rather than one that operates a public copay-card division. If cost is your barrier rather than availability, a free discount card usually does more for you here than searching for a manufacturer coupon that likely doesn't exist for this particular brand.
For a side-by-side breakdown of discount card providers, our Inside Rx vs. SingleCare comparison and Inside Rx review cover how these programs price controlled substances like clonazepam differently from brand-name maintenance drugs.
8. Brand Klonopin vs. Generic Clonazepam: Full Comparison
| Factor | Brand Klonopin (H2 Pharma) | Generic Clonazepam |
|---|---|---|
| Current availability | Reported available | Available except Teva's 0.5 mg / 2 mg |
| Active ingredient | Clonazepam | Same (bioequivalent) |
| Typical cash price (30-day supply) | Often $100+ | Roughly $25–$45, less with a discount card |
| Standard insurance tier | Usually non-preferred once generic exists | Usually preferred, low tier |
| Manufacturer coupon / PAP | None publicly offered by current distributor | None; use discount cards instead |
| Refill flexibility | Up to 5 refills in 6 months, Schedule IV rules | Same — Schedule IV rules apply equally |
| Best option when | Cost isn't the concern and your pharmacy stocks it | Nearly always, given the price gap |
Sticking with generic clonazepam
- Far cheaper cash price, and usually the lower-tier option on insurance
- Four separate manufacturers besides Teva currently report full availability
- Same Schedule IV refill and transfer rules apply, so switching pharmacies is easy
Switching to brand Klonopin
- Cash price is roughly triple generic, with no manufacturer coupon to offset it
- Insurance will likely still steer you back to generic once it's back in local stock
- Not necessary from a supply standpoint, since only one generic maker is actually short
9. Step-by-Step: If Your Pharmacy Is Out
Ask which manufacturer they stock
Given that this shortage sits almost entirely with Teva, this one question often resolves the whole problem. If your pharmacy carries Teva and is out, ask whether they can order from Accord, Solco, or Chartwell instead.
Check whether you have refills left
Because clonazepam allows up to five refills over six months, you may not need a new prescription at all. If you do have refills remaining, a different pharmacy can often pull them via transfer without any prescriber involvement.
Call two or three other pharmacies
Independent pharmacies and different chains often use different wholesalers, so a store a few miles away may have full stock even if your usual location is affected.
Ask about the 1 mg strength if your dose allows
Teva's back order specifically covers 0.5 mg and 2 mg tablets, not 1 mg. If your prescriber is open to it, two 0.5 mg tablets or a temporary 1 mg-based regimen could bridge a short gap — but this is a clinical decision, not something to change on your own.
If nothing is available anywhere, call your prescriber before you run out
This is a fallback, not the first step, since most patients solve this at the pharmacy level. But if every nearby pharmacy is genuinely out of every manufacturer, your prescriber can write a new prescription specifying a different manufacturer or a short bridge plan.
Don't stop abruptly while you sort this out
Clonazepam withdrawal can include rebound anxiety, insomnia, and in some patients, seizure risk. If you're down to your last few doses with no clear plan, contact your prescriber rather than waiting until you're out completely.
10. Cost-Lowering Options
Because clonazepam is inexpensive as a generic, most patients don't need formal assistance programs the way patients on branded specialty drugs do. Still, a few paths are worth knowing.
- Discount cards: Free cards like Inside Rx typically bring generic clonazepam well below its unassisted cash price. Our Inside Rx vs. SingleCare breakdown compares current pricing across major discount platforms.
- Broader assistance search: Refill Relay's guide to prescription assistance programs and our explainer on how patient assistance programs work cover options beyond manufacturer-specific programs, useful since brand Klonopin doesn't run one of its own.
- Medicare enrollees: Review our guide to 2026 Part D changes and check whether Medicare patients can use patient assistance programs for your specific plan and situation.
- Extra Help (Low-Income Subsidy): If your income and assets fall within Medicare's published limits, Extra Help can substantially lower what you pay for covered Part D drugs, including clonazepam when it's on your plan's formulary.
- Prior authorization denials: If your plan denies coverage or applies step therapy, our prior authorization and appeal guide walks through the process for major pharmacy benefit managers.
11. Eligibility & Income Limits Compared
These options use different rules and different income tests, so it's worth comparing them directly rather than assuming one applies to your situation.
| Program | Who It's For | Income Basis | Covers |
|---|---|---|---|
| Discount cards (Inside Rx, SingleCare, GoodRx) | Anyone, regardless of income or insurance status | No income requirement | Generic clonazepam and most common generics |
| Medicare Extra Help (LIS) | Medicare Part D enrollees with limited income and resources | Federal income and asset limits, updated annually by CMS | Covered Part D drugs, including clonazepam if on formulary |
| NeedyMeds / BenefitsCheckUp | Anyone searching for assistance across many programs at once | Varies by the specific program matched | Aggregates discount programs and state/local resources |
| State pharmacy assistance programs | State residents meeting state-specific income rules | Set by individual state; varies widely | Varies by state program |
| Manufacturer PAP (brand Klonopin) | Not currently offered | — | — |
Where to check current numbers: Medicare's Extra Help income and resource limits are published and updated by CMS through Medicare.gov. Discount card pricing changes frequently and isn't standardized, so compare your specific pharmacy's cash price against your card's quoted price before assuming either is cheaper.
12. Application Process, Approval Timelines & Renewal
Discount cards
- Apply: No application. Free to sign up online or use immediately at the pharmacy counter.
- Timeline: Instant. Present the card or app code at checkout.
- Renewal: None required; these cards don't expire the way insurance plans do.
Medicare Extra Help
- Apply: Through the Social Security Administration or your state Medicaid office, online, by phone, or in person.
- Documentation: Income and resource information for you and your spouse, if applicable.
- Timeline: Processing times vary, but approved eligibility can often be applied retroactively for the current plan year.
- Renewal: Some enrollees are automatically re-evaluated annually; others need to reapply. Check your notice from Social Security for your specific requirement.
Refilling clonazepam itself
- Refill window: Up to five refills within six months of the original prescription date, per Schedule IV rules.
- Transfer: Most pharmacies can transfer remaining refills to another location by phone; some states cap the number of transfers, so ask directly.
- After refills run out: Your prescriber needs to issue a new prescription; this cannot be extended further by the pharmacy alone.
13. Common Mistakes That Delay Access
- Assuming the whole medication is unavailable. This shortage is one manufacturer and two strengths; most patients can solve it by switching pharmacies or manufacturers, not by waiting.
- Not checking for remaining refills before calling your prescriber. Schedule IV rules mean you may already have what you need without any new paperwork.
- Only calling pharmacies within the same chain. Different chains and independents often stock different manufacturers, and this shortage is manufacturer-specific.
- Assuming brand Klonopin has a coupon like other brand drugs. It generally doesn't right now, so don't delay filling generic while searching for one.
- Waiting until you're out to start looking. Even a manufacturer-specific gap is easier to solve with a few days of lead time than none.
- Stopping the medication on your own if you can't get a refill immediately. Talk to your prescriber about a short bridge plan instead; abrupt discontinuation carries real risk with this drug class.
14. Withdrawal Safety: Don't Stop Cold
This matters more than the shortage itself. Clonazepam is a benzodiazepine, and regular use leads to physical dependence relatively quickly. Stopping abruptly, whether by choice or because a prescription genuinely can't be filled, can trigger withdrawal symptoms ranging from rebound anxiety and insomnia to, in more severe cases, seizures, particularly in patients being treated for a seizure disorder in the first place.
If you're down to a few days' supply and haven't been able to locate any manufacturer's clonazepam nearby, contact your prescriber's office before your last dose, not after. A short-term plan, whether that's a different pharmacy, a different manufacturer, or a temporary dose adjustment, is a clinical decision your prescriber needs to make with you.
15. Decision Tree: What Should You Do Right Now?
Ask about a new prescription written for a manufacturer that's currently in stock, or a short bridge plan. Don't stop taking clonazepam on your own while you sort this out.
Related: Adderall Shortage 2026: When Will It End, XR Status & What to Do Now
If you manage a clonazepam prescription alongside a Schedule II stimulant, this guide explains why that shortage behaves so differently and what the DEA quota system actually controls.